PortfoliosLab logoPortfoliosLab logo
SAN.PA vs. XRP-USD
Performance
Return for Risk
Drawdowns
Volatility

Performance

SAN.PA vs. XRP-USD - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Sanofi (SAN.PA) and XRP (XRP-USD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

SAN.PA is traded in EUR, while XRP-USD is traded in USD. To make them comparable, the XRP-USD values have been converted to EUR using the latest available exchange rates.

Returns By Period

In the year-to-date period, SAN.PA achieves a -2.23% return, which is significantly higher than XRP-USD's -37.42% return.


SAN.PA

1D
0.38%
1M
4.57%
YTD
-2.23%
6M
-2.94%
1Y
-6.83%
3Y*
-2.17%
5Y*
1.20%
10Y*
5.46%

XRP-USD

1D
0.00%
1M
-23.02%
YTD
-37.42%
6M
-42.70%
1Y
-47.32%
3Y*
30.25%
5Y*
5.86%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SAN.PA vs. XRP-USD - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
SAN.PA
Sanofi
-2.23%-7.87%8.77%3.64%4.92%16.86%-8.97%23.41%10.36%-3.49%
XRP-USD
XRP
-37.42%-22.05%255.79%75.16%-55.92%306.34%4.58%-44.08%-83.33%32,043.81%

Correlation

The correlation between SAN.PA and XRP-USD is -0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.05

Correlation (3Y)
Calculated over the trailing 3-year period

-0.02

Correlation (5Y)
Calculated over the trailing 5-year period

0.03

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2017

0.02

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SAN.PA vs. XRP-USD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SAN.PA
SAN.PA Risk / Return Rank: 2626
Overall Rank
SAN.PA Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
SAN.PA Sortino Ratio Rank: 2525
Sortino Ratio Rank
SAN.PA Omega Ratio Rank: 2525
Omega Ratio Rank
SAN.PA Calmar Ratio Rank: 2727
Calmar Ratio Rank
SAN.PA Martin Ratio Rank: 2626
Martin Ratio Rank

XRP-USD
XRP-USD Risk / Return Rank: 5858
Overall Rank
XRP-USD Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
XRP-USD Sortino Ratio Rank: 5656
Sortino Ratio Rank
XRP-USD Omega Ratio Rank: 5454
Omega Ratio Rank
XRP-USD Calmar Ratio Rank: 6868
Calmar Ratio Rank
XRP-USD Martin Ratio Rank: 6060
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SAN.PA vs. XRP-USD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sanofi (SAN.PA) and XRP (XRP-USD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SAN.PAXRP-USDDifference
Sharpe ratioReturn per unit of total volatility

+0.39

Sortino ratioReturn per unit of downside risk

+0.62

Omega ratioGain probability vs. loss probability

0.96

0.90

+0.06

Calmar ratioReturn relative to maximum drawdown

-0.47

-0.69

+0.21

Martin ratioReturn relative to average drawdown

-0.85

-1.08

+0.23

SAN.PA vs. XRP-USD - Sharpe Ratio Comparison

The current SAN.PA Sharpe Ratio is -0.32, which is higher than the XRP-USD Sharpe Ratio of -0.71. The chart below compares the historical Sharpe Ratios of SAN.PA and XRP-USD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SAN.PA vs. XRP-USD - Drawdown Comparison

The maximum SAN.PA drawdown since its inception was -43.30%, smaller than the maximum XRP-USD drawdown of -95.28%. Use the drawdown chart below to compare losses from any high point for SAN.PA and XRP-USD.


Loading charts...

Drawdown Indicators


SAN.PAXRP-USDDifference

Max Drawdown

Largest peak-to-trough decline

-43.30%

-95.28%

+51.98%

Max Drawdown (1Y)

Largest decline over 1 year

-16.18%

-68.72%

+52.54%

Max Drawdown (3Y)

Largest decline over 3 years

-27.80%

-70.38%

+42.58%

Max Drawdown (5Y)

Largest decline over 5 years

-27.80%

-74.75%

+46.95%

Max Drawdown (10Y)

Largest decline over 10 years

-30.35%

Current Drawdown

Current decline from peak

-22.98%

-69.46%

+46.48%

Average Drawdown

Average peak-to-trough decline

-13.52%

-69.61%

+56.09%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.92%

43.82%

-34.90%

Volatility

SAN.PA vs. XRP-USD - Volatility Comparison

The current volatility for Sanofi (SAN.PA) is 6.61%, while XRP (XRP-USD) has a volatility of 12.97%. This indicates that SAN.PA experiences smaller price fluctuations and is considered to be less risky than XRP-USD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SAN.PAXRP-USDDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.61%

12.97%

-6.36%

Volatility (6M)

Calculated over the trailing 6-month period

15.36%

45.84%

-30.48%

Volatility (1Y)

Calculated over the trailing 1-year period

24.04%

55.39%

-31.35%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.77%

71.24%

-48.47%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

21.35%

103.17%

-81.82%

Frequently Asked Questions


SAN.PA and XRP-USD have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for SAN.PA and XRP-USD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer